EMA Recommends Extension of Indications for Dostarlimab By Ogkologos - January 23, 2025 637 0 Facebook Twitter Google+ Pinterest WhatsApp Change concerns the first-line treatment of patients with endometrial cancer Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR ESMO Breast Cancer Congress 2022 April 20, 2022 Study Tests Immunotherapy in People with Cancer and Autoimmune Diseases August 26, 2019 Spending Review 2021: Promising commitments, but a lot of unanswered questions October 27, 2021 Selpercatinib Shows Durable Efficacy in RET-Altered Thyroid Cancer August 28, 2020 Load more HOT NEWS Adding More Mushrooms to Your Diet May Decrease Your Risk of... Is there a right way to check your body for cancer? Investment Needed to Bring Down Pancreatic Cancer Death Rates in Europe.... Our COVID-19 Response: How GreaterGood Is Making An Impact During The...
